Back to Media

Daymon Industry Update: BHA

The U.S. Food and Drug Administration (FDA) has launched a review of the chemical preservative butylated hydroxyanisole (BHA), putting renewed scrutiny on an ingredient widely used across food categories.

For retailers and manufacturers that produce private brands, this review has real implications. Understanding where BHA shows up in your portfolio today can help you stay ahead of potential disruption tomorrow.

  • A snapshot of the FDA’s BHA review
  • Insight into which product categories may face the greatest exposure
  • Action steps to manage portfolio updates
This update also includes an overview of Daymon services and technology designed to help retailers and suppliers navigate ingredient removal and reformulation with confidence and efficiency.

Download Daymon’s Industry Update: BHA